thalassemia and hemoglobinopathies

131

Upload: huy

Post on 12-Jan-2016

86 views

Category:

Documents


9 download

DESCRIPTION

Thalassemia and Hemoglobinopathies. Ahmad Shihada Silmi Msc, FIBMS Staff Specialist in Hematology Medical Technology Department Islamic University of Gaza. Quiz. What is structure of hemoglobin A? What is the normal hemoglobin types in normal adults? - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Thalassemia and  Hemoglobinopathies
Page 2: Thalassemia and  Hemoglobinopathies

Thalassemiaand

Hemoglobinopathies

Ahmad Shihada Silmi Msc, FIBMS

Staff Specialist in Hematology

Medical Technology Department

Islamic University of Gaza

Page 3: Thalassemia and  Hemoglobinopathies

QuizQuiz What is structure of hemoglobin A? What is the normal hemoglobin types in

normal adults? Hemoglobin is composed of………..

and……… There are …. types of globin chains which

are…….. Normally, rate of globin chain production is

equal or not equal.

Page 4: Thalassemia and  Hemoglobinopathies

Hb-A Molecule. Hb-A is the major Hb-A Molecule. Hb-A is the major adult hemoglobin.adult hemoglobin.

Page 5: Thalassemia and  Hemoglobinopathies

Thalassemia Syndromes arising form

decreased rate or absence of globin chain synthesis.

The resulting imbalance-globin chain synthesis takes place, giving rise to the excess amount of the normally synthesized globin chain.

Page 6: Thalassemia and  Hemoglobinopathies

ThalassemiasThalassemias

Page 7: Thalassemia and  Hemoglobinopathies

HemoglobinopathiesHemoglobinopathies The syndrome arising from the

synthesis of abnormal hemoglobin or hemoglobin variants.

Rate of globin chain synthesis are theoritically normal.

Abnormal hemoglobins have different properties from the normal ones.

Page 8: Thalassemia and  Hemoglobinopathies

HemoglobinopathiesHemoglobinopathies

Page 9: Thalassemia and  Hemoglobinopathies
Page 10: Thalassemia and  Hemoglobinopathies
Page 11: Thalassemia and  Hemoglobinopathies

Incidence of thalassemia in Thailand

-thalassemia : 20-30 % -thalassemia : 3-9 % Hb E : 8-70 % (very high in E-sarn) Hb Constant Spring : 1-6 % Thalassemia disease : 1%

Page 12: Thalassemia and  Hemoglobinopathies

Mode of inheritance Autosomal recessive Heterozygote or double

heterozygote are not affected. Homozygote or compound

heterozygote are affected.

Page 13: Thalassemia and  Hemoglobinopathies

HHow to name thalassemia?ow to name thalassemia?

Named after globin chain that is abnormally synthesized !!!!

Reduced or absent -globin chain : -thalassemia Reduced or absent -globin chain : -thalassemia Reduced or absent -globin chain : -thalassemia Reduced or absent -globin chain : -thalassemia Reduced or absent -globin chains : -thalassemia

Page 14: Thalassemia and  Hemoglobinopathies

Common types of thalassemia

-thalassemia -thalassemia

Page 15: Thalassemia and  Hemoglobinopathies

ALPHA THALASSEMIAS

Page 16: Thalassemia and  Hemoglobinopathies

αα Thalassemia Thalassemia

Absence of α chains will result in

increase/ excess of globin chains during fetal life and excess β globin chains later in postnatal life.

Severity of disease depends on number of genes affected.

Page 17: Thalassemia and  Hemoglobinopathies

SymbolismAlpha Thalassemia

( )/ :Indicates division between genes inherited from both parents:

/ )Normal)

• Each chromosome 16 carries 2 genes. Therefore the total complement of genes in an individual is 4.

Page 18: Thalassemia and  Hemoglobinopathies

SymbolismAlpha Thalassemia

)-) : Indicates a gene deletion:

-/ + Thalassemia )one gene deletion)

- 3 functional working genes.- Called thal 2.

Page 19: Thalassemia and  Hemoglobinopathies

SymbolismAlpha Thalassemia

)-) : Indicates a gene deletion:

--/ 0 Thalassemia )two gene deletion) in

the same chromosome.

- 2 functional working genes.- Called thal 1.

Page 20: Thalassemia and  Hemoglobinopathies

SymbolismSymbolismOther ThalassemiaOther Thalassemia

Superscript T denotes nonfunctioning )mutated gene, not deletion) gene:

T

Page 21: Thalassemia and  Hemoglobinopathies

Classification & TerminologyAlpha Thalassemia

• Normal / • Silent carrier - / • Minor -/-

--/• Hb H disease --/-• Barts hydrops fetalis --/--

Page 22: Thalassemia and  Hemoglobinopathies

αα Thalassemia Thalassemia

Defects in α globin affecting the formation of both fetal and adult hemoglobins, thus, producing intrauterine as well as postnatal disease. Unlike β thalassemia, why??

Page 23: Thalassemia and  Hemoglobinopathies

αα Thalassemia Thalassemia The most common cause of α thalassemia is

due to α gene/s deletions. The most likely mechanism for α gene deletion

is due to homologous pairing between α1 and α2 and recombination. This results in loss of α gene. Other causes of α thalassemias are deletions in the locus control regions (HS40( or chain termination mutations (nonsense mutations(.

Page 24: Thalassemia and  Hemoglobinopathies

Types of thalassemia

-thalassemia-1 or o-thalassemia (--)

-thalassemia-2 or +-thalassemia (-)

Page 25: Thalassemia and  Hemoglobinopathies

Deletion of -globin gene cluster

Page 26: Thalassemia and  Hemoglobinopathies

Deletion causing -thalassemia-2

Page 27: Thalassemia and  Hemoglobinopathies

Compound heterozygotes

Hb H disease ( --/-)

Hb Bart’s hydrops fetalis syndrome

(--/--)

Page 28: Thalassemia and  Hemoglobinopathies

αα Thalassemia Thalassemia

2 1 2 1

2

2 1

2 1

2 1

2 1

2 1

2 1

Normal Hb

One α gene deletion

α-Thal2

Two α gene deletions

α-Thal1

Three α gene deletions

Hb-H disease

Four α gene deletions

Hydrops fetalis or also called:

Erythroblastosis Fetalis.

Page 29: Thalassemia and  Hemoglobinopathies

αα Thalassemia Thalassemia As said, the genetic basis of α thal is mostly deletions: If

you have 4 functional α genes, then you are normal. With 3 functional α genes, you are a silent carrier. With 2 functional α genes you have α thalassemia trait

which is clinically benign, but there is mild microcytic anemia.

With only one functional α chain, you have severe hemolytic anemia with primarily HbH, composed of 4 β chains (β4(. This is clinically severe.

In the absence of α chain in the fetus, the gamma forms a tetramer of globin chains, and is called Hb Bart’s.

Both Hb-H and Hb-Barts are high affinity Hbs, thus neither of them is capable of releasing oxygen to the tissues, also these hemoglobins are fast moving hemoglobins in Hb electrophoresis at alkaline pH.

Page 30: Thalassemia and  Hemoglobinopathies

αα Thalassemia Thalassemia Infants with severe α Thalassemia )zero

functional alpha genes) and Hb Barts suffer from severe intrauterine hypoxia and are born with massive generalized fluid accumulation, a condition known as hydrops fetalis or also called erythroblastosis fetalis.

Page 31: Thalassemia and  Hemoglobinopathies

Thus: in α Thalassemia• Is usually caused by deletion of 1 or more of

the 4 α globin genes on chromosome 16

• Severity of disease depends on number of the deleted α genes.

• Absence of α chains will result in increase/

excess of chains during fetal life and excess β chains later in life;  Causes hemoglobins like

Hb Bart's )4) or HbH )β4), to form which are physiologically useless )very high affinity).

• Like β thalassemia the excess globin chains causes the problem.

Page 32: Thalassemia and  Hemoglobinopathies

But:But:

Alpha chain accumulation and deposition are more toxic than beta chain accumulation and deposition. Thus beta thalassemia is more severe than alpha thalassemia.

Page 33: Thalassemia and  Hemoglobinopathies

αα Thalassemia: Hb-H Disease Thalassemia: Hb-H Disease

Page 34: Thalassemia and  Hemoglobinopathies

α Thalassemia

• Predominant cause of alpha thalassemias is large number of gene deletions in the α-globin genes.

• There are four clinical syndromes present in alpha thalassemia: ♫ Silent Carrier State ♫ Alpha Thalassemia Trait  (Alpha Thalassemia Minor( ♫ Hemoglobin H Disease ♫ Bart's Hydrops Fetalis Syndrome

Page 35: Thalassemia and  Hemoglobinopathies

Silent Carrier Silent Carrier αα Thalassemia Thalassemia

-α/αα One alpha gene deletion, 3 intact alpha

genes. Healthy persons. Normal Hb and Hct No treatment Can only be detected by DNA studies.

Page 36: Thalassemia and  Hemoglobinopathies

Alpha Thalassemia Trait

• Also called Alpha Thalassemia Minor. • Caused by two missing alpha genes.  May be

homozygous (-α/-α( or heterozygous (--/αα(. • Exhibits mild microcytic, hypochromic anemia. • MCV between 70-75 fL.• Normal Hb electrophoresis. WHY??? • May be confused with iron deficiency anemia.

• Although some Bart's hemoglobin (4( present at birth, but no Bart's hemoglobin present in adults.

Page 37: Thalassemia and  Hemoglobinopathies

Hemoglobin H DiseaseHemoglobin H Disease Second most severe form alpha thalassemia. Usually caused by presence of only one intact

α gene producing alpha chains )--/-α).  Results in accumulation of excess unpaired

gamma or beta chains. Born with 10-40% Bart's hemoglobin )4).   Gradually replaced with Hemoglobin H )β4). In adult, have about 5-40% HbH.

γγ4 4 ββ44

Page 38: Thalassemia and  Hemoglobinopathies

Hemoglobin H Disease Hemoglobin H Disease Live normal life; however, infections,

pregnancy, exposure to oxidative drugs may trigger hemolytic crisis.

RBCs are microcytic, hypochromic with marked poikilocytosis.  Numerous target cells.

Hb 7-10 g/dl Hb electrophoresis: Fast moving band

correspondent to HbH. HbH vulnerable to oxidation.  Gradually

precipitate in vivo to form Heinz-like bodies of denatured hemoglobin.  Cells been described has having "golf ball" appearance, especially when stained with Brilliant Cresyl Blue.

Page 39: Thalassemia and  Hemoglobinopathies
Page 40: Thalassemia and  Hemoglobinopathies

Hb-H preparationHb-H preparation

Same preparation as Retic count stain, but with extended time of incubation, instead of 15 minutes, 2 hours incubation is required.

Page 41: Thalassemia and  Hemoglobinopathies

Hb-H inclusionsHb-H inclusions

Page 42: Thalassemia and  Hemoglobinopathies

Blood Smear & HbH PreparationBlood Smear & HbH Preparation

Page 43: Thalassemia and  Hemoglobinopathies

Bart’s Hydrops Fetalis Syndrome

• Most severe form.  Incompatible with life.  Have no functioning α chain genes (- -/- -(.

• Baby born with hydrops fetalis, which is edema and ascites caused by accumulation serous fluid in fetal tissues as result of severe anemia.  Also we will see hepatosplenomegaly and cardiomegaly.

• Predominant Hb is Hb Bart, along with Hb Portland and traces of HbH.

• Hb Bart's has high oxygen affinity so cannot carry oxygen to tissues.  Fetus dies in utero or shortly after birth. At birth, you will see severe hypochromic, microcytic anemia with numerous NRBCs.

Page 44: Thalassemia and  Hemoglobinopathies

Hydrops Fetalis

The blood film of neonate with hemoglobin Bart’s hydrops fetalis showing anisocytosis, poikilocytosis and numerous nucleated red blood cells (NRBC(.

Page 45: Thalassemia and  Hemoglobinopathies
Page 46: Thalassemia and  Hemoglobinopathies
Page 47: Thalassemia and  Hemoglobinopathies

NRBCs in newbornNRBCs in newborn

Only and only the presence of few NRBCs in the peripheral blood of the newborn is considered normal.

Page 48: Thalassemia and  Hemoglobinopathies

State Genotype Genes Features

Normal / 4 normal

Hetero +

-thal-2/ – 3 Essentially normal

Hetero °-thal-1

/ – – 2 Micro / HypoMild AnemiaBart’s 2-8% (at birth(

Hb H <2%Homo +

-thal-1– / – 2

+ + °Hb-H Disease

– / – – 1 Moderate Micro/Hypo anemia: Barts <10%, Hb H <40%

homo °Hydrops

– – / – – 0 Hb A 0%, Bart’s 70-80%Portland 10-20%

Page 49: Thalassemia and  Hemoglobinopathies

Comparison of Comparison of αα Thalassemias Thalassemias

Phenotype Hb A Hb Barts Hb H

Normal 97-98% 0 0

Silent Carrier 96-98% 0-2%

)At birth)

0

α Thalassemia Trait 85-95% 2-8%

)At birth)

<2%

Hb H Disease Dec <10%

)At birth)

5-40%

Hydrops Fetalis 0 70-80% )with 20% Hb Portland)

0-20%

Page 50: Thalassemia and  Hemoglobinopathies

Hb-Bart’sHb-Bart’s Is only detected at birth. But then

disappears )WHY???). So diagnosis of alpha thalassemia could be established at birth directly in comparison of beta thalassemia.

Page 51: Thalassemia and  Hemoglobinopathies

αα Thalassemia Syndromes Thalassemia Syndromes

Page 52: Thalassemia and  Hemoglobinopathies

Hb electrophoresis at Alkaline pH mobilityHb electrophoresis at Alkaline pH mobility

Page 53: Thalassemia and  Hemoglobinopathies

• They are the most important types of thalassemias because they are so common and usually produce severe anemia in their homozygous and compound heterozygous states (compound= when combined with other hemoglobinopathies or thalassemias(

thalassemias are autosomal inherited disorders of globin synthesis. In most, globin structure is normal but the rate of production is reduced because of decrease in transcription of DNA, abnormal processing of pre-mRNA, or decreased translation of mRNA leading to decreased Hb-A production (A=Adult(.

ββ Thalassemia Thalassemia

Page 54: Thalassemia and  Hemoglobinopathies

ββ Thalassemia Thalassemia

Usually and mostly they are caused by gene mutations in the gene in chromosome# 11, although deletions do occur.

Hundreds of mutations possible in the globin gene, therefore thalassemia is more diverse disease in its presentation (the presentation differs between people depending on the type of mutation(.

This results in excess alpha chains, because they cannot find their counterparts (the beta chains( to bind to.

Page 55: Thalassemia and  Hemoglobinopathies

Excess alpha chainsExcess alpha chains

Page 56: Thalassemia and  Hemoglobinopathies

Type of mutations that could occur

Immature mRNA Immature mRNA transcripttranscript

5’ 3’

Gene (DNA(Gene (DNA(

TranscriptionTranscription

TranslationTranslation

ProteinProteinNH2NH2 COOHCOOH

exon1exon1 intron1intron1 exon2exon2 intron2intron2 exon3exon3 ((AAAAAA ( (signalsignal

Promoter/EnhancerPromoter/Enhancer

55’’ exon1exon1 exon2exon2 exon3exon3 AAAA…AAA 3AAAA…AAA 3’’ Mature mRNA Mature mRNA transcripttranscript

ATGATG““startstart””

““stop” stop” codoncodon

ProcessingProcessing

5’ 3’exon1exon1 exon2exon2 exon3exon3 AAAA…AAAAAAA…AAA

XX XX

XX XX

XX

XX

Page 57: Thalassemia and  Hemoglobinopathies

The classes of mutations thatThe classes of mutations thatunderlie underlie β-β-thalassaemiathalassaemia

Page 58: Thalassemia and  Hemoglobinopathies

Thalassemia inheritanceThalassemia inheritance

Page 59: Thalassemia and  Hemoglobinopathies

Again:Again:

β thalassemias are usually and mostly due to single base pair substitutions rather than deletions. Although deletions do occur.

Page 60: Thalassemia and  Hemoglobinopathies

Beta (ß) thalassemia

It appears when a person does not produce enough beta chains for hemoglobin .

It is mainly prevalent in the Mediterranean region countries , such as Greece, Cyprus,

Italy, Palestine and Lebanon.

Page 61: Thalassemia and  Hemoglobinopathies

ß thalassemia and malaria

•Thalassemic RBCs offers protection against severe malaria caused by

Plasmodium falciparum.•The effect is associated with reduced

parasite multiplication within RBCs.•Among the contributing factors may be

the variable persistence of hemoglobin F, which is relatively resistant to digestion

by malarial hemoglobinases.

Page 62: Thalassemia and  Hemoglobinopathies

β Thalassemia :The Story in Brief

• The molecular defects in β thalassemia result in the absence or varying reduction )according to the type of mutation) in β chain production. α-Chain synthesis is unaffected and hence there is imbalanced globin chain production, leading to an excess of α-chains. In the absence of their partners )β chains), they are unstable and precipitate in the red cell precursors, giving rise to large intracellular inclusions that interfere with red cell maturation. Hence there is a variable degree of intramedullary destruction of red cell precursors, i.e. ineffective erythropoiesis.

Page 63: Thalassemia and  Hemoglobinopathies

The Story in Brief, continueThe Story in Brief, continue

Those red cells which escape ineffective erythropoiesis and mature and enter the circulation contain α-chain inclusions that interfere with their passage through the RES, particularly the spleen. The degradation products of excess α-chains, particularly heme and iron, produce deleterious effects on red cell membrane proteins and lipids. The end result is an extremely rigid red cell with a shortened survival )i.e. hemolysis).

Page 64: Thalassemia and  Hemoglobinopathies

In brief:In brief: The anemia is due to two main components:

– Ineffective erythropoiesis (intramedullary(.– Extravascular Hemolysis in RES esp. spleen

A third component that could contribute for the severity of anemia is Splenomegaly that may also worsen the anemia, because of two components: the )1) increased sequestration, and )2) increased plasma volume caused by the splenomegaly )dilutional).

Page 65: Thalassemia and  Hemoglobinopathies

There is also:

• Extramedullary erythropoiesis occurs, which also contributes for the splenomegaly, it is worthy to note that extramedullary erythropoiesis is not a perfect process, this is why in thalassemias we may see tear drop RBCs, and nucleated RBCs )NRBCs). Although, the NRBC seen in the blood film are from both the BM and the extramedullary erythropoiesis.

Page 66: Thalassemia and  Hemoglobinopathies

The pathophysiology of The pathophysiology of β-β-thalassaemiathalassaemia

Page 67: Thalassemia and  Hemoglobinopathies

• This occurs in utero when embryonic hemoglobins switch to HbF. Also it occurs postnatal when HbF is switched to HbA.

• Hb switching requires coordination of numerous genetic, cellular and signaling factors during periods of human development.

Page 68: Thalassemia and  Hemoglobinopathies

At what age could At what age could ββ Thalassemia cause Thalassemia cause its effect???its effect???

In contrast to α globin, β globin is not necessary during fetal life )Hb-F= α2γ2), thus the onset of β Thalassemia isn’t apparent until a few months after birth, when HbF is switched to HbA.

Page 69: Thalassemia and  Hemoglobinopathies

Types of Types of ββThalassemiaThalassemia

Three common types of Thalassemia: Thalassemia: The production of chain is mildly

reduced. Thalassemia: The production of chain is more

reduced than But NOT ABSENT. and are caused by mutation in Promoter region, 5`UTR, Cap site, Consensus sites, within Introns, 3`UTR, or Poly A site, and change in coding region.

Thalassemia: ABSENCE of chain production. It is caused by mutation in Initiation codon, Splicing at junctions, Frameshift, Nonsense mutation.

Page 70: Thalassemia and  Hemoglobinopathies

In and thalassemias, the mutated gene encodes for a small amounts of normal mRNA. The quantity of globin chain, which are made, varies largely from one molecular mutation/defect to another.

Excess α chains will precipitate in the RBC precursor cells and causes the ineffective erythropoiesis, also if it escape intramedullary ineffective erythropoiesis, RBCs possessing precipitated α chains will be hemolyzed in the P.B. by the RES (esp. in spleen(.

Page 71: Thalassemia and  Hemoglobinopathies

ThalassemiaThalassemiaTThe he ββ gene is unable to encode for any functional mRNA gene is unable to encode for any functional mRNA

and therefore there is and therefore there is nono chain synthesis. So the situation chain synthesis. So the situation will be more difficult than will be more difficult than thalassemia.thalassemia.

More excess α chains will precipitate in RBC precursor cells and causes the ineffective erythropoiesis, also if it escape ineffective erythropoiesis, red cell possessing precipitated alpha chains will be hemolyzed in the P.B. by the RES (esp. in the spleen(.

Page 72: Thalassemia and  Hemoglobinopathies

Thus:Thus:

Thus the anemia in Thalassemia will be more difficult than and thalassemias.

You got it or not yet. Am I right??!

Page 73: Thalassemia and  Hemoglobinopathies

mRNA quantity differs between

alpha and beta, so there will be free

alpha chains that will precipitate in

red cells.

Page 74: Thalassemia and  Hemoglobinopathies

Again: What is Thalassemia?

• A group of inherited single gene disorders resulting in reduced or no production of one or more globin chains

• This results in an imbalance of globin chain production, with the normal excess chain producing the pathological effects: ♪ Damage to RBC precursors →ineffective red cell

production in BM. ♪ Damage to mature red cells → hemolytic anemia

• Resulting in hypochromic, microcytic anemia

Page 75: Thalassemia and  Hemoglobinopathies

Each one of us inherit one gene Each one of us inherit one gene from each parentfrom each parent

β Gene

β Gene

β Gene

β Gene

β Gene

β Gene

Homozygous: Normal Both gene are normal

Heterozygous: one normal and one

abnormal/mutated

Homozygous: Abnormal Both gene are

abnormal/mutated

XXXXXX

Page 76: Thalassemia and  Hemoglobinopathies

Quantities of β globin chain produced in different genetic situations depends on the mutation type.

Homozygous Heterozygous

xx

xx xx

Page 77: Thalassemia and  Hemoglobinopathies

Who is at risk?Ethnic origin is very critical!

Page 78: Thalassemia and  Hemoglobinopathies

Classical Clinical Syndromes of Thalassemia; thalassemia can be presented as:

o Silent carrier state – mildest form of thal. thalassemia minor - heterozygous disorder

resulting in mild hypochromic, microcytic hemolytic anemia.

thalassemia intermedia - Severity lies between the minor and major.

thalassemia major - homozygous disorder resulting in severe life long transfusion-dependent hemolytic anemia.

Page 79: Thalassemia and  Hemoglobinopathies

Silent Thal ++/N

Thal. trait

++/ ++

+/ N

o / N

Thal. intermedia

++/ +

++/ o

+/ +

+/ o

o/ o

Thal. major

There is overlap in

presentation

Summary of Phenotype/Genotype Relationship in Thalassemia

Page 80: Thalassemia and  Hemoglobinopathies

Silent Carrier State for β Thalassemia

• Are various heterozygous )from one parent) β gene mutations that produce only small decrease in production of β globin chains.

• Patients have nearly normal alpha/beta chain ratio and no hematologic abnormalities.

• Have normal levels of HbA2.

Page 81: Thalassemia and  Hemoglobinopathies

β Thalassemia Minor (Trait)

• Caused by heterozygous (from one parent( mutations that affect β globin synthesis.

• β Chains production and thus Hb-A production is more reduced than the silent carrier Hb-A. 

• Usually presents as mild, asymptomatic hemolytic anemia unless patient in under stress such as pregnancy, infection, or folic acid deficiency.

• Have one normal β gene and one mutated β gene. • Hemoglobin level in 10-13 g/dL range with normal

or slightly elevated RBC count (RCC(.

Page 82: Thalassemia and  Hemoglobinopathies

ββ Thalassemia Minor Thalassemia Minor (Trait) (Trait)

Anemia usually hypochromic and microcytic with slight aniso and poik, including target cells and elliptocytes;  also may see basophilic stippling.

Rarely see hepatomegaly or splenomegaly. Have high HbA2 levels (3.6-8.0%( and normal to

slightly elevated HbF levels. Normally require no treatment.  You have to make sure are not diagnosed as IDA. Mentzer index: <13 (Why?(.

Page 83: Thalassemia and  Hemoglobinopathies

ββ Thalassemia Minor Thalassemia Minor (Trait)(Trait)

2- 6% HbF (N = < 1% after age 1 year( 3.6 - 8% HbA2 (N = 2.2-3.6%( 87 - 95% HbA (N=95-100%(

Page 84: Thalassemia and  Hemoglobinopathies
Page 85: Thalassemia and  Hemoglobinopathies

ββ thalassemia minor thalassemia minor

Page 86: Thalassemia and  Hemoglobinopathies

Distinguishing thalassaemia minor from IDA from CBC by applying formulae:

Formula Thal. IDA

MCV RCC (Mentzer index(

<13 >13

MCH RCC < 3.8 > 3.8

(MCV2 MCH( 100 < 1530 > 1530

MCV – RCC – (Hb 5( – 3.4 < 0 > 0

(MCV2 RDW( (100xHb( < 65 > 65

RDW-CV% <14.6 >14.6

Page 87: Thalassemia and  Hemoglobinopathies

ββ Thalassemia Intermedia Thalassemia Intermedia

Patients able to maintain minimum Hb (7 g/dL or greater( without transfusion dependence. 

Expression of disorder falls between thalassemia minor and thalassemia major.

We will see increase in both HbA2 production and HbF production.

Peripheral blood smear picture is similar to thalassemia minor.

Page 88: Thalassemia and  Hemoglobinopathies

ββ Thalassemia Intermedia Thalassemia Intermedia Have varying symptoms of anemia,

jaundice, splenomegaly and hepatomegaly. Have significant increase in bilirubin levels.  Anemia usually becomes worse with

infections, pregnancy, or folic acid deficiency.

May become transfusion dependent. Tend to develop iron overloads as result of

increased gastrointestinal absorption. Usually survive into adulthood.

Page 89: Thalassemia and  Hemoglobinopathies

ββ Thalassemia Major Thalassemia Major

Characterized by very severe microcytic, hypochromic anemia. 

Detected early in childhood: Hb level lies between 2 and 8 g/dL. Severe anemia causes marked bone changes

due to expansion of marrow space for increased erythropoiesis (Epo is increased(.

See characteristic changes in skull, long bones, and hand bones. 

Page 90: Thalassemia and  Hemoglobinopathies

ββ Thalassemia Major Thalassemia Major Have protrusion upper teeth and Mongoloid facial

features.  Physical growth and development delayed. Peripheral blood shows markedly hypochromic,

microcytic erythrocytes with extreme poikilocytosis, such as target cells, teardrop cells (WHY??( and elliptocytes.  See marked basophilic stippling and numerous NRBCs. 

MCV in range of 50 to 60 fl. Retic count seen (2-8%(. But low for the degree of

anemia. RPI<2. Most of Hemoglobin present is Hb F with slight

increase in HbA2.

Page 91: Thalassemia and  Hemoglobinopathies

ββ Thalassemia Major Thalassemia Major Regular transfusions usually begin around one year of

age and continue throughout life.  Excessive number of transfusions results in

tranfusional hemosiderosis; Without iron chelation, patient develops cardiac disease, liver cirrhosis, and endocrine deficiencies.

Dangers in continuous tranfusion therapy: – Development of iron overload. – Development of alloimmunization (developing antibodies to

transfused RBCs(. – Risk of transfusion-transmitted diseases (e.g. hepatitis, AIDS(.

Bone marrow transplants may be future treatment, along with genetic engineering and new drug therapies.

Page 92: Thalassemia and  Hemoglobinopathies

β Thalassemia Major

Page 93: Thalassemia and  Hemoglobinopathies

β Thalassemia Major

Anisopoikilocytosis, NRBC, microcytosis, hypochromia

Page 94: Thalassemia and  Hemoglobinopathies

β Thalassemia Major

Target cells, NRBC, microcytosis, poikilocytosis

Page 95: Thalassemia and  Hemoglobinopathies

Cooley’s AnemiaCooley’s Anemia

This is another name for β Thalassemia Major, because Cooley was the first one to describe these cases.

Page 96: Thalassemia and  Hemoglobinopathies

Good point for you to know!

• In iron def. anemia the severity of anemia correlates will with the degree of microcytosis. This means when the anemia gets more worse the MCV gets lower and lower.

• While in thalassemia minor either beta or alpha the MCV is out of proportion with the degree of anemia. This means that the MCV will be much lower than expected for the minimal reduction in Hb.

Page 97: Thalassemia and  Hemoglobinopathies

Thalassemic face

Page 98: Thalassemia and  Hemoglobinopathies

Thalassemia faceThalassemia face

Page 99: Thalassemia and  Hemoglobinopathies

ββ Thalassemia MajorThalassemia Major

Page 100: Thalassemia and  Hemoglobinopathies

Expansion of BM

Page 101: Thalassemia and  Hemoglobinopathies

β thalassemia majorMale 18 years

Page 102: Thalassemia and  Hemoglobinopathies

Hepatosplenomegaly

Page 103: Thalassemia and  Hemoglobinopathies
Page 104: Thalassemia and  Hemoglobinopathies

Hair on End Appearance

Page 105: Thalassemia and  Hemoglobinopathies

Dark skin due to iron overload

Page 106: Thalassemia and  Hemoglobinopathies

Thalassaemia major-life expectancy

• Without regular transfusion– Less than 10 years

• With regular transfusion and no or poor iron chelation– Less than 25 years

• With regular transfusion and good iron chelation– 40 years, or longer??

Page 107: Thalassemia and  Hemoglobinopathies

Thalassemics: Blood Transfusion

Page 108: Thalassemia and  Hemoglobinopathies

Good iron chelation using desferoxamine (iron chelator) Good iron chelation using desferoxamine (iron chelator) prolongs the life expectancy of Cooley’s anemic patients, prolongs the life expectancy of Cooley’s anemic patients, otherwise cardiac failure, liver cirrhosis, and endocrine otherwise cardiac failure, liver cirrhosis, and endocrine

deficiencies could occur and causing death. deficiencies could occur and causing death.

Page 109: Thalassemia and  Hemoglobinopathies

Comparison of β Thalassemias

Parameter Minor Intermedia Major

Hb 10-13 6-10 2-8

MCV (fl( 60-78 50-70 50-60

MCH (pg( 28-32 22-28 16-22

RDW Normal S. increased IncreasedMicro/hypo Film Mild Moderate Severe

Polychromasia V. Little Moderate Marked

Anisocytosis None Moderate Marked

Poikilocytosis None Moderate Marked

Targetting Present Present Present

Page 110: Thalassemia and  Hemoglobinopathies

Comparison of β Thalassemias

GENOTYPE Hb A Hb A2 Hb F

NORMAL Normal Normal Normal

SILENT CARRIER Normal Normal Normal

β THAL MINOR Dec N to Inc N to Inc

β THAL INTERMEDIA Dec N to Inc Increased

β THAL MAJOR Dec Usually Inc Increased

Page 111: Thalassemia and  Hemoglobinopathies

Hereditary persistence of fetal hemoglobin (HPFH(

• Expressing -globin genes at the same level in adult life as in fetal life.

• HPFH homozygotes have only HbF )22) and no anemia!

• HPFH heterozygous have 20-30% HbF. In acid elution test: all RBCs contain Hb-F. Pancellular distribution of HbF. This means that all cells are F cells.

Page 112: Thalassemia and  Hemoglobinopathies

δβδβ Thalassemia Thalassemia

In some cases: They result from deletions of the δ and

β globin genes. Homozygotes have 100% Hb-F, with

moderate anemia 8-10 g/dl. With microcytosis and hypochromia.

Heterozygotes have 15-25% Hb-F.

Page 113: Thalassemia and  Hemoglobinopathies

δβδβ Thalassemia Thalassemia Where as in others: They appear to have unequal crossing over

between the δ and β globin gene loci with the production of δβ fused gene which codes for δβ fused globin chains that when combine to α chains forms an abnormal hemoglobin called Hb Lepore, which have an electrophoretic mobility like sickle hemoglobin.

Page 114: Thalassemia and  Hemoglobinopathies
Page 115: Thalassemia and  Hemoglobinopathies

δβδβ Thalassemia: Classification Thalassemia: Classification

Because there are two causes for delta beta thalassemia: deletions and fusion. Delta Beta thalassemias can be classified into:– (δβ0( thalassemia: caused by complete deletion

of δβ genes. Homozygotes characterized by 100% HbF. With moderate anemia 8-10 g/dl.

– (δβ+( thalassemia: or called Hb Lepore thalassemia. Homozygotes have only HbF and Hb Lepore.

Page 116: Thalassemia and  Hemoglobinopathies

Heterocellular distribution of HbF.Heterocellular distribution of HbF.

In delta beta thalassemia not all cells are F cells. So the distribution of HbF in heterocellular, when performing acid elution test. This means not all cells are F cells in comparison to HPFH.

Page 117: Thalassemia and  Hemoglobinopathies
Page 118: Thalassemia and  Hemoglobinopathies

HemoglobinopathiesHemoglobinopathies

Production of abnormal globin chains.

Abnormal hemoglobins are the synthesised : structural variants.

Abnormal hemoglobin has different property from its counterpart.

Rate of synthesis of abnormal globin chain is reduced, resembling mild form of thalassemia

Page 119: Thalassemia and  Hemoglobinopathies

Structural Variants(469 var submitted, July 2002)

Hb Anantharaj cd11(Lys-Glu) Hb Mahidol cd74(Asp-His) Hb Siam cd15(Gly-Arg)

Hb Suan Dok cd109(Leu-Arg) Hb Constant

spring cd142(stop-Gln)

Page 120: Thalassemia and  Hemoglobinopathies

Hb Constant Spring Point mutation at termination

codon UAA-->CAA 31 amino acids extension Total amino acid = 172 Phenotype similar to +-

thalassemia

Page 121: Thalassemia and  Hemoglobinopathies

Hb Constant SpringHb Constant Spring Sense mutations involve change from a stop

codon to one that codes for an amino acid. E.g. Hemoglobin Constant Spring alpha 142 UAA )Stop codon) CAA )Gln). Translation continues beyond the normal termination until another stop codon )UAA, or UAG, or UGA) is encountered, this causes 31 amino acids elongation. Alpha chain is normally 141 amino acids, but here it is 172 amino acids.

Page 122: Thalassemia and  Hemoglobinopathies

-Structural Variants (649 var submitted, July 2002)

Hb D-Punjab cd121(Glu-Gln) Hb J-Bangkok cd56(Gly-Asp) Hb S cd6(Glu-Val)

Hb G-Siriraj cd7(Glu-Lys) Hb Tak cd147(+AC) Hb E cd26(Glu-Lys)

Page 123: Thalassemia and  Hemoglobinopathies

Hemoglobin E

Commonly found in Thais Result of point mutation at codon 26 of -globin gene. Glutamic acid-->Lysine Phenotype similar to +-thalassemia

Page 124: Thalassemia and  Hemoglobinopathies

Hemoglobin S

Commonly found among the black. Cause of sickle cell anemia. Result of point mutation at

codon 6 of -globin gene; Glutamic acid-->Valine

Hb S can perform polymerization, esp. when deoxygenated.

Page 125: Thalassemia and  Hemoglobinopathies

Compound heterozygote and homozygote

Homozgous -thalassemia (T/T)

Hb E disease/-thalassemia (T/E)

Page 126: Thalassemia and  Hemoglobinopathies

Order of Severity

Hb Bart’s hydrops fetalis. -thalassemia major. -thalassemia/Hb E disease. AE Bart’s and EF Bart’s disease. Hb H disease.

Page 127: Thalassemia and  Hemoglobinopathies

Pathogenesis and Pathophysiology

Imbalanced globin chain synthesis. Excess of normal globin chain. Precipitation of excess globin chain. Degradation of precipitated globin. Release of oxygen free radicle. Ineffective erythropoiesis

Page 128: Thalassemia and  Hemoglobinopathies

Pathogenesis and Pathophysiology (cont.)

Membrane lipid peroxidation. Loss of deformability. Loss of lipid asymmetry

(Normally: PC/SM; out, PS/PE; in.) Entrapped by spleen and

destroyed (extravascular hemolysis)

Page 129: Thalassemia and  Hemoglobinopathies

Clinical Symptoms

Anemia, Jaundice. Hepatosplenomegaly. Bone change-->mongoloid face. Iron overload-->growth

retardation, heart failure, DM, dark-colored skin , etc.

Page 130: Thalassemia and  Hemoglobinopathies

Management Blood transfusion Iron chelation: Desferroxamine,

Deferiprone (L1), ExjadeTM

Splenectomy Stem cell transplantation : BM

or Cord blood Prenatal diagnosis (PND) Supportive: Folic acid

Page 131: Thalassemia and  Hemoglobinopathies

References

Weatherall DJ & Clegg JB. (1981) The Thalassemia Syndromes. Blackwell Scientific: Oxford.

Rodgers GP (Ed) (1998) Bailliere’s Clinical Haematology: International Practice and Research (Sickle cell disease and Thalassemia. Bailliere’s Tindall: London.

Bunn HF, Forget BG, Ranney HM.(1977) Human Hemoglobins. WB Saunders Company: Philadelphia.

http://globin.cse.psu.edu/ (Accessed July 16, 2002) http://sickle.bwh.harvard.edu/alpha_two.gif (Accessed July 18,

2002)